Product Image

Omega-3

Solgar
4.8
★ ★ ★ ★ ★
(49203 ratings)
EPA (Eicosapentaenoic Acid) 1008 mg
DHA 756 mg
Fish Oil 2800 mg
Product Image
Score87
A potent, well-balanced fish oil with good value and basic oxidation protection, limited by source and purity disclosure gaps.
How scoring works
Quantity:100 Softgel(s) • (50 servings)
Goals:
Anti-Inflammatory Support
Heart Health
Cardiovascular Support
Vision Support
Mental Focus

Score 87

A potent, well-balanced fish oil with good value and basic oxidation protection, limited by source and purity disclosure gaps.
How scoring works
$31.75($0.63 per serving)
Pure Formulas
$ 33.74
iHerb
$ 32.05
Daily Vita
$ 37.12
Vitacost
$ 31.75
Report prices

Analysis

Two softgels supply 1,008 mg EPA and 756 mg DHA. Those amounts provide substantial depth for cardiovascular, inflammatory, brain, and vision support.

Mixed natural tocopherols offer basic oxidation protection. The fish species, molecular form, purification process, and independent contaminant testing are not disclosed.

The active-dose value is good for a concentrated formula. It is useful for long-term nutritional support, though it does not provide an immediate focus effect or eye-specific carotenoids.

Who is it for
  • Adults seeking high EPA and DHA intake
  • People targeting heart, inflammatory, brain, or vision support
  • Users comfortable with two softgels
Best for
  • Broad marine omega-three support
  • High-dose cardiovascular routines
  • Long-term brain and vision nutrition

Pros

  • High EPA and DHA amounts
  • Good active-oil concentration
  • Mixed tocopherols protect the oil

Cons

  • Fish species and molecular form are unstated
  • No purification method supplied
  • No independent testing disclosed

Warnings

  • Fish oil may increase bleeding tendency with anticoagulants
  • Avoid with a fish allergy
  • High active amounts may cause reflux or loose stools

Nutrient quality

89 Highest impact

The substantial EPA and DHA amounts create a potent, coherent fish-oil formula with no obvious padding. Missing molecular-form detail prevents full confidence in absorption quality.

.

Ingredient transparency

90 Highest impact

All meaningful fatty-acid amounts and the listed excipients are disclosed without a hidden blend. Fish species, oil form, purification, and independent testing are not stated.

.

Customer satisfaction

72 High impact

The aggregate rating is strong and backed by very high review volume. No review text is supplied to assess recurring complaints or whether firsthand experiences match the intended use.

.

Value for money

92 Highest impact

High active concentration gives each serving strong practical value. Better source, form, and purity documentation would strengthen the comparison with premium fish oils.

.
Report analysis

Goals

Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA- Strength of SupportB+ CoverageA+ Formula Quality
Fish Oil · 2800 mgVitamin E · NP

EPA and DHA are foundational precursors for specialized pro-resolving mediators that help the body turn down inflammation. The clearly disclosed combined amount provides strong targeted support with good active-oil concentration.

Mixed tocopherols help protect the oil from oxidation. The molecular form, purification method, fish species, sustainability status, and independent testing are not disclosed, leaving important quality uncertainties.

Study evidence
Fish Oil Supportive 68 studies
Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 1008 mg

The serving provides substantial EPA and DHA amounts that directly support triglyceride management and broader cardiovascular function. EPA is clearly higher than DHA, creating a strong heart-health dose with useful focused depth.

The fish-oil molecular form is not identified, and no independent contaminant testing or purification evidence is provided. Mixed tocopherols offer basic oxidation protection, but stronger quality verification would improve confidence in a concentrated marine-oil product.

Study evidence
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A Goal FitB+ Strength of SupportC CoverageA Formula Quality
Fish Oil · 2800 mgVitamin E · NP

EPA and DHA directly support triglyceride management and cardiovascular membrane function. Fish oil has strong human evidence for lowering triglycerides at adequate doses.

The combined EPA and DHA amount reaches a strong cardiovascular range. EPA and DHA are separately disclosed and tocopherols protect the oil, but molecular form and purity testing are absent.

Study evidence
Fish Oil Supportive 185 studies
Vision Support
Vision Support
Impact
Highest effect
B+ Goal FitB+ Strength of SupportC+ CoverageA Formula Quality
Vitamin E · NPEPA (Eicosapentaenoic Acid) · 1008 mg

The combination of 756 mg DHA and 1,008 mg EPA provides strong structural and ocular-surface support. DHA is directly relevant to retinal membranes, while EPA may complement it through inflammatory signaling.

The exact fatty-acid amounts are clear and natural tocopherols offer basic oxidation protection. Fish-oil molecular form and independent purity testing are not disclosed, and the formula does not provide macular carotenoids or a full antioxidant-mineral system.

Study evidence
Mental Focus
Mental Focus
Impact
High effect
D+ Goal FitA Strength of SupportC CoverageA+ Formula Quality

High disclosed amounts of EPA and DHA support brain-cell membranes and a healthy inflammatory response. Those effects may help the background conditions for concentration but are not acute focus mechanisms.

The formula is potent and transparent, yet its benefit is likely to be gradual and most relevant when omega-3 intake is low. Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence

Ingredients

IngredientAmount per serving
Fish Oil Concentrate
2800 mg
Eicosapentaenoic Acid
1008 mg
Docosahexaenoic Acid
756 mg
Gelatin
0 NP
Glycerin
0 NP
Mixed Natural Tocopherols
0 NP
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
EPA (Eicosapentaenoic Acid) · 1008 mg OverallScore64
D+ Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB+ Value

The serving delivers a substantial EPA amount with EPA clearly higher than DHA. Its fish-oil form is not identified, and the label gives no purity certification or contaminant-testing details. Efficient EPA delivery and basic tocopherol protection help balance those disclosure gaps.

View ingredientView products
DHA · 756 mg OverallScore59
C- Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyB+ Value

The serving provides a high DHA amount and a reasonably concentrated blend of DHA and EPA. Mixed natural tocopherols may help protect the oil, but the DHA chemical form and contaminant testing are not disclosed. Cost efficiency is good for the active amount, while the generic fish source limits traceability.

View ingredientView products
Fish Oil · 2800 mg OverallScore58
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The serving provides a substantial combined EPA and DHA dose with a high active-oil concentration. Individual EPA and DHA amounts are clear, and mixed tocopherols help protect the oil from oxidation. The molecular form, purification method, independent testing, and fish species are not disclosed, leaving important quality and sourcing questions unresolved.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>Its ingredient profile may be preferable when the stated EPA-and-DHA balance matches the intended use. Triglyceride fish oil delivers a highly concentrated EPA-led omega-3 serving with clear fatty-acid amounts and especially favorable package value. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
<p>Its ingredient profile may be preferable when the stated EPA-and-DHA balance matches the intended use. A substantial, clearly separated EPA and DHA serving offers strong potency and active value. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
83 Performance

Super Omega-3

Life Extension
<p>Its ingredient profile may be preferable when the stated EPA-and-DHA balance matches the intended use. A substantial EPA-and-DHA serving gains compatible antioxidant support from quantified olive and sesame compounds. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
76 Budget

Omega-3 Fish Oil 1000 mg Lemon

Natrol
<p>It has a lower listed serving cost while retaining clearly described omega-3 actives. The low-cost fish oil suits basic omega-3 intake, with EPA and DHA clearly listed. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
79 Budget

Omega-3 Fish Oil with Vitamin D 1000 mg Lemon Flavored

Swanson
<p>It has a lower listed serving cost while retaining clearly described omega-3 actives. Vitamin D3 adds useful breadth to a clearly quantified but modest omega-3 serving. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
70 Budget

Omega-3 Salmon Oil

Bluebonnet
<p>It has a lower listed serving cost while retaining clearly described omega-3 actives. The simple fish-oil formula clearly lists EPA and DHA, but the active amount is modest and dilute within the oil. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
85 Value

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>It combines useful EPA-and-DHA coverage with practical serving value. Triglyceride fish oil delivers a highly concentrated EPA-led omega-3 serving with clear fatty-acid amounts and favorable value. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
84 Value

Mega EPA/DHA

Life Extension
<p>It combines useful EPA-and-DHA coverage with practical serving value. A substantial EPA-and-DHA dose with natural vitamin E provides strong depth and excellent active value. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
84 Value

Fish Oil 1400 mg

Nature's Bounty
<p>It combines useful EPA-and-DHA coverage with practical serving value. A meaningful EPA-led amount and strong oil concentration provide good active value. By comparison, the high, clearly disclosed EPA and DHA amount makes the formula useful for substantial omega-3 support.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  5. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  8. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  10. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  11. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  12. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  13. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  14. What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review.
    Pameijer EM; Heus P; Damen JAA; Spijker R; Hooft L; Ringens PJ; Imhof SM; van Leeuwen R · Acta ophthalmologica · 2023
    Systematic review27 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  15. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  16. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  17. Association between fatty acid intake and age-related macular degeneration: a meta-analysis.
    Lee Y; Lee L; Zhang L; Zhou Q · Frontiers in nutrition · 2024
    Meta-analysisVision Support forEPA (Eicosapentaenoic Acid)
  18. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration.
    Merle BM; Benlian P; Puche N; Bassols A; Delcourt C; Souied EH; Nutritional AMD Treatment 2 Study Group · Investigative ophthalmology & visual science · 2014
    Case-control study434 participantsVision Support forEPA (Eicosapentaenoic Acid)
  19. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  20. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  21. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  22. Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration.
    Wu J; Cho E; Giovannucci EL; Rosner BA; Sastry SM; Willett WC; Schaumberg DA · Ophthalmology · 2017
    Cohort study114,850 participantsVision Support forEPA (Eicosapentaenoic Acid)
  23. ASSOCIATION OF PLASMA ω-3 FATTY ACIDS WITH EARLY AGE-RELATED MACULAR DEGENERATION IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS.
    Karger AB; Guan W; Nomura SO; Weir NL; Klein BEK; Burke GL; Johnson WC; Tsai MY · Retina (Philadelphia, Pa.) · 2022
    Cohort study3,772 participantsVision Support forEPA (Eicosapentaenoic Acid)
  24. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  25. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  26. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  27. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  28. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  29. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  30. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  31. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  32. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  33. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  34. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  35. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  36. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)